Data / Drug companies / Phenazopyridine hydrochloride
Phenazopyridine hydrochloride: 53 companies and 90 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Phenazopyridine hydrochloride is listed in the FDA National Drug Code Directory by 53 companies, with 90 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; kit; tablet, film coated, and the newest product started marketing on August 4, 2026.
The request: Get every company that lists phenazopyridine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 53
- Products
- 90
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Maximum Strength Urinary Pain Relief, Preferred Maximum Strength Urinary Pain Relief, Quality Choice Urinary Pain Relief, Good Neighbor Pharmacy Urinary Pain Relief, Quality Choice Maximum Strength Urinary Pain Relief, Foster and Thrive Neighbor Pharmacy Urinary Pain Relief, Foster and Thrive Maximum Strength Urinary Pain Relief, Care One Maximum Strength Urinary Pain Relief
- openFDA record search
- api.fda.gov
Companies that list phenazopyridine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 4 | tablet | Other unapproved drugs | October 19, 2023 |
| Proficient Rx LP | 4 | tablet | Other unapproved drugs | October 19, 2023 |
| Reese Pharmaceutical Co | 4 | tablet | Other unapproved drugs | May 24, 2023 |
| A-S Medication Solutions | 3 | tablet | Other unapproved drugs | October 19, 2023 |
| Kroger Company | 3 | tablet | Other unapproved drugs | May 1, 2021 |
| Preferred Pharmaceuticals Inc. | 3 | tablet | Other unapproved drugs | June 4, 2026 |
| Remedyrepack Inc. | 3 | tablet | Other unapproved drugs | January 15, 2024 |
| Strategic Sourcing Services LLC | 3 | tablet | Other unapproved drugs | July 20, 2023 |
| Walgreen Company | 3 | tablet | Other unapproved drugs | October 10, 2019 |
| Amerisource Bergen | 2 | tablet | Other unapproved drugs | July 2, 2020 |
| Bonafide Health, LLC DBA Uqora | 2 | kit; tablet | Other unapproved drugs | November 10, 2025 |
| Bryant Ranch Prepack | 2 | tablet | Other unapproved drugs | October 19, 2023 |
| Cardinal Health 110, LLC. DBA Leader | 2 | tablet | Other unapproved drugs | October 10, 2019 |
| Chain Drug Marketing Association | 2 | tablet | Other unapproved drugs | August 15, 2019 |
| Chain Drug Marketing Association, Inc. | 2 | tablet | Other unapproved drugs | December 2, 2025 |
| Chartwell RX, LLC | 2 | tablet | Other unapproved drugs | August 23, 2011 |
| Genus Lifesciences | 2 | tablet | Other unapproved drugs | June 8, 2026 |
| Redpharm Drug | 2 | tablet | Other unapproved drugs | October 19, 2023 |
| Rising Pharma Holdings, Inc. | 2 | tablet | Other unapproved drugs | December 6, 2023 |
| Rite Aid Corporation | 2 | tablet | Other unapproved drugs | November 25, 2019 |
| Strategic Sourcing Services LLC | 2 | tablet | Other unapproved drugs | September 12, 2019 |
| Strive Pharmaceuticals Inc. | 2 | tablet, film coated; tablet | Other unapproved drugs | January 6, 2025 |
| Topco Associates LLC | 2 | tablet | Other unapproved drugs | July 1, 2013 |
| Westminster Pharmaceuticals, LLC | 2 | tablet | Other unapproved drugs | October 19, 2023 |
| Winder Laboratories LLC | 2 | tablet | Other unapproved drugs | December 23, 2015 |
| Advanced Rx LLC | 1 | tablet | Other unapproved drugs | May 1, 2024 |
| CVS Pharmacy | 1 | tablet | Other unapproved drugs | September 18, 2019 |
| Cadence Health, Inc. | 1 | tablet | Other unapproved drugs | April 6, 2026 |
| Chain Drug Consortium, LLC | 1 | tablet | Other unapproved drugs | July 31, 2019 |
| Clarion Brands, LLC | 1 | tablet | Over the counter monograph drugs | August 2, 2024 |
| Discount Drug Mart | 1 | tablet | Other unapproved drugs | January 4, 2010 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | tablet | Other unapproved drugs | October 3, 2019 |
| Family Dollar (family Wellness) | 1 | tablet | Other unapproved drugs | January 4, 2010 |
| GPT Pharmaceuticals Private Ltd | 1 | tablet | Other unapproved drugs | April 1, 2026 |
| Get Stix Inc. | 1 | tablet | Other unapproved drugs | September 30, 2020 |
| Harris Teeter, LLC | 1 | tablet | Other unapproved drugs | December 23, 2019 |
| Insight Pharmaceuticals LLC | 1 | tablet | Other unapproved drugs | March 1, 2025 |
| Ixxa, Inc | 1 | tablet | Other unapproved drugs | May 12, 2021 |
| Medtech Products Inc. | 1 | tablet | Other unapproved drugs | February 15, 2018 |
| Meijer Distribution Inc | 1 | tablet | Other unapproved drugs | August 29, 2019 |
| Nuvicare LLC | 1 | tablet | Other unapproved drugs | August 4, 2026 |
| Pioneer Life Sciences, LLC | 1 | tablet | Other unapproved drugs | July 21, 2026 |
| Proficient Rx LP | 1 | tablet | Other unapproved drugs | July 1, 2013 |
| Retail Business Services, LLC | 1 | tablet | Other unapproved drugs | September 20, 2019 |
| Rugby Laboratories | 1 | tablet | Other unapproved drugs | December 7, 2023 |
| Safeway | 1 | tablet | Other unapproved drugs | December 23, 2019 |
| Shopko Stores Operating Co., LLC | 1 | tablet | Other unapproved drugs | July 1, 2013 |
| Sportpharm LLC | 1 | tablet | Other unapproved drugs | July 20, 2023 |
| Strategic Sourcing Services LLC | 1 | tablet | Other unapproved drugs | July 1, 2013 |
| Target Corporation | 1 | tablet | Other unapproved drugs | January 25, 2023 |
| Wal-Mart Stores Inc | 1 | tablet | Other unapproved drugs | October 10, 2019 |
| Yyba Corp | 1 | tablet | Other unapproved drugs | April 1, 2026 |
| i-Health, Inc. | 1 | tablet | Other unapproved drugs | July 2, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 88 | 97.8% |
| Kit | 1 | 1.1% |
| Tablet, film coated | 1 | 1.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 89 | 98.9% |
| Over the counter monograph drugs | 1 | 1.1% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.